| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,878 | 9,583 | 10,190 | 13,811 | | Cost of Revenue | 5,630 | 5,223 | 6,649 | 11,045 | | | Gross Profit | 8,248 | 4,360 | 3,541 | 2,766 | | | Operating Expenses | | Research Development | 4,689 | 5,069 | 5,789 | 7,949 | | Selling General and Administrative | 4,321 | 4,108 | 4,413 | 4,432 | | Non Recurring | 1,743 | 1,202 | 633 | 68,760 | | Others | 86 | 87 | 87 | 310 | | | | Total Operating Expenses | 10,839 | 10,466 | 10,922 | 81,451 | | | | Operating Income or Loss | (2,591) | (6,106) | (7,381) | (78,685) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (210) | 324 | (44) | | Earnings Before Interest And Taxes | (2,584) | (6,316) | (7,057) | (78,729) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,584) | (6,316) | (7,057) | (78,729) | | Income Tax Expense | 247 | 322 | 264 | 322 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,831) | (6,638) | (7,321) | (79,051) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,831) | (6,638) | (7,321) | (79,051) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,831) | ($6,638) | ($7,321) | ($79,051) |
|
0.01% Nasdaq 
Income Statement
